Serina Therapeutics, Inc. Other Current Assets
Serina Therapeutics, Inc. (SER) had Other Current Assets of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Current $0.00.
- 2026-03-31: Other Assets, Current $333.00K.
- 2025-12-31: Other Assets, Current $309.00K.
- 2025-09-30: Other Assets, Current $170.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $333.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $309.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $170.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $177.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $150.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $77.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $143.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-09 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-24 |
| 2020-09-30 | $71.73K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |